Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

Can Stem Cell Therapy cure Parkinson’s Disease?

No. Stem cell therapy does not cure Parkinson's disease, and no current treatment can stop it or replace the dopamine-producing neurons that have been lost.

Free Consultation
Brain location on a neutral human figure

What mesenchymal stem cells (MSCs) can offer is support: they release anti-inflammatory and neuroprotective signals that may reduce inflammation in the nervous system and support the remaining neurons, and some patients report improvements in stiffness, movement, balance, energy or overall well-being. A clinical trial of allogeneic MSC infusions in people with Parkinson's, published in Movement Disorders, found the treatment safe and well tolerated. At Stem Cell Mexico, Parkinson's protocols use only allogeneic MSCs from Wharton's jelly of the umbilical cord, usually by intravenous (IV) infusion and, in selected cases after the doctor reviews your medical reports, by an additional intrathecal application. Treatment complements your neurologist's care and medications such as levodopa, results vary between patients, and Parkinson's plans typically cost $7,000 to $9,500 USD.

This guide explains why Parkinson's is managed rather than cured, what different stem cell approaches aim to do, what MSCs can realistically support and how treatment fits with your current care.

Understanding Parkinson's disease

According to the National Institute of Neurological Disorders and Stroke (NINDS, NIH), Parkinson's disease is a progressive condition in which nerve cells that produce dopamine, in a brain region called the substantia nigra, gradually stop working or die. Dopamine is essential for smooth, coordinated movement.

Common symptoms include:

  • Tremor, often starting in one hand.
  • Slowness of movement (bradykinesia).
  • Stiffness (rigidity) of the limbs and trunk.
  • Balance problems and changes in walking.
  • Non-motor symptoms: loss of smell, constipation, sleep disturbances, low mood, anxiety, fatigue and changes in thinking.

Symptoms usually appear after a large proportion of dopamine neurons has already been lost, and the disease progresses gradually over years.

Why Parkinson's is managed rather than cured

The dopamine neurons lost in Parkinson's are not replaced by the body. Current treatments work by replacing or enhancing dopamine signaling and by managing symptoms:

  • Medications such as levodopa, dopamine agonists and MAO-B inhibitors.
  • Deep brain stimulation (DBS) for selected patients.
  • Physical, occupational and speech therapy, and regular exercise, which improve mobility, balance and quality of life.

These treatments are effective for symptoms, and they remain the foundation of care.

Two different stem cell strategies

Cell replacement

Researchers are developing dopamine-producing neurons grown from stem cells and transplanted surgically into the brain. A phase I trial published in Nature in 2025 showed that this approach was safe in the participants studied, with encouraging signs, and further trials are under way at specialized centers. This is a surgical, research-based approach.

Supportive MSC therapy

MSCs are not designed to become dopamine neurons. Instead, they release signals that may:

  • Reduce neuroinflammation, which contributes to the progression of Parkinson's.
  • Support the survival of remaining neurons through trophic factors.
  • Modulate the immune system.
  • Support energy and overall function.

This is the approach used at Stem Cell Mexico.

What MSCs can realistically support

Based on what patients and families tell us, potential benefits some patients experience include:

  • Less stiffness and smoother movement.
  • Better balance and coordination.
  • More energy and better daily function.
  • Improved overall quality of life.

Responses vary: some patients notice clear changes, others modest ones and some little difference. MSC therapy is not designed to stop disease progression or replace medications.

What the evidence shows

  • Safety in Parkinson's: a clinical trial of allogeneic bone-marrow-derived MSC infusions in people with Parkinson's, published in Movement Disorders in 2021, found the infusions safe and well tolerated, with signals of improvement in motor scores and inflammatory markers in some participants.
  • Safety of umbilical cord MSCs: a 2026 meta-analysis of IV umbilical-cord-derived MSCs in Stem Cells Translational Medicine found temporary fever as the most consistent side effect, without an increase in serious infection, thrombosis, cancer or death in controlled trials.
  • Cell replacement research: a 2025 phase I trial in Nature of stem-cell-derived dopamine neurons showed safety and encouraging signs.

How treatment fits with your Parkinson's care

  • Medications continue exactly as prescribed; MSC therapy does not replace levodopa or other drugs.
  • Your neurologist remains in charge of your Parkinson's treatment.
  • Exercise and therapy remain essential and may help you make the most of any improvement.
  • DBS patients can be evaluated; the team reviews device precautions.

Safety considerations specific to Parkinson's

  • Medication interactions: if you take an MAO-B inhibitor such as rasagiline, selegiline or safinamide, certain pain medications, including tramadol and meperidine, must be avoided. The team reviews every medication given during your stay.
  • Fever and infections: fever after an infusion is usually mild and temporary, but infections such as urinary tract infections can temporarily worsen Parkinson's symptoms, so any persistent fever is checked promptly.
  • Falls: staff help with transfers and walking in an unfamiliar environment.
  • Swallowing: tell the team about swallowing difficulties, so medication support can be adapted and your companion can plan suitable meals.

Parkinson's plans typically cost $7,000 to $9,500 USD, and the exact figure is confirmed in your written plan.

What our patients usually receive

Based on the treatment plans our team prepares for Parkinson's patients, a typical protocol at Stem Cell Mexico includes:

  • Wharton's jelly MSCs by IV infusion, usually between 100 and 200 million cells, depending on body weight and medical review.
  • An additional intrathecal application (similar to an epidural, usually about 60 million cells) in selected cases, only after the doctor reviews your medical reports and confirms you are a candidate.
  • One night at our facilities, sometimes two, with nursing and medical monitoring.
  • Consultation with your doctor and the stem cell specialist, pre-treatment laboratory tests and ground transportation from the San Diego airport area.

Recovery is gradual, and each person responds differently. Some patients notice changes within the first weeks, while others notice them over the following months. Our team stays in contact after treatment to follow your progress and decide whether a second application could help.

How to measure what changes

  • Motor symptoms: the MDS-UPDRS scale, recorded by your neurologist.
  • Walking and balance: timed walking tests and fall frequency.
  • Daily function: dressing, eating, writing and other activities.
  • "Off" time: how many hours per day medications are not working well.
  • Non-motor symptoms: sleep, energy, mood and constipation.
  • Videos: short recordings of walking and hand movements before and after treatment.

Recording these at baseline and at three and six months gives you and your neurologist an objective picture.

What helps alongside any treatment

Several measures have strong support in Parkinson's care and add to the benefit of any treatment:

  • Regular exercise, including walking, cycling, dance, tai chi or boxing-based programs, which improve mobility, balance and mood.
  • Physical, occupational and speech therapy, tailored to your symptoms.
  • Consistent medication timing, which reduces "off" periods.
  • Good sleep, and evaluation of sleep problems, which are common in Parkinson's.
  • Fall prevention at home, such as removing rugs, adding grab bars and improving lighting.
  • Attention to mood, since depression and anxiety are common and treatable.

Questions families often ask

Can my loved one travel safely? In most cases, yes, with planning. Our driver meets you in the San Diego airport area, and wheelchair assistance can be arranged. A companion is welcome during the visit.

Will the visit interfere with medication timing? No. Medications are taken on their usual schedule, including on the day of treatment. Bring enough for the whole trip plus extra days.

When will we know if it helped? Changes, when they occur, are usually gradual. Comparing walking, daily function and symptom diaries at three and six months with the baseline is more reliable than impressions in the first days.

Who may be a candidate

  • Confirmed Parkinson's disease, with neurology records and a current medication list.
  • Medically stable, able to travel with appropriate support.
  • No active infection and no cancer within the past five years.
  • Continued care with a neurologist.

Warning signs when comparing clinics

Be cautious if a clinic promises to cure Parkinson's, suggests stopping medications, claims cells will become new dopamine neurons after an IV infusion or says the treatment is risk-free.

Questions to ask during your evaluation

  • What changes could be realistic at my stage of Parkinson's?
  • Am I a candidate for IV only, or also for an intrathecal application?
  • How will my medications be managed during the visit?
  • How will we measure results, and when?

Bottom line

Stem cell therapy does not cure Parkinson's disease, but Wharton's jelly MSCs can support the nervous system through anti-inflammatory and neuroprotective signals, with a reassuring safety record, and some patients report less stiffness, better balance or more energy. At Stem Cell Mexico, treatment complements your neurologist's care and medications, and results vary between patients. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your symptoms, goals and medical history.

References

  1. National Institute of Neurological Disorders and Stroke (NINDS, NIH): Parkinson's disease (opens in a new tab)
  2. Schiess M et al. Allogeneic bone marrow-derived mesenchymal stem cell safety in idiopathic Parkinson's disease. Movement Disorders, 2021 (opens in a new tab)
  3. Tabar V et al. Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease. Nature, 2025 (opens in a new tab)
  4. Hum C et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026 (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation